Oxford Properties Group has completed the conversion of Boren Labs, a 136,000 square foot life sciences facility in South Lake Union. The completed project, previously known as Boren Lofts, and developed by Trammell Crow, is located at 1930 Boren Ave. Oxford acquired the building for $119,000,000 in April 2021 as part of its entry into the Seattle market.
Seven of the building’s nine life sciences floors have been leased during construction. The building’s 15,000 sq ft floor plates and prebuilt lab suites are intended for younger life sciences companies, who need access to smaller operational spaces as quickly as possible following fundraising.
In addition to nine levels of lab and support office space, Boren Labs has ground level retail and an amenity floor with a shared rooftop deck and conference center. The building has 15-foot floor-to-floor heights, fully upgraded MEP systems and subsurface parking. Each floor has a private deck with outdoor access.
The building is primarily occupied by Seattle-area companies, largely in the biotech field, working on vaccines, gene and cell therapy. Occupants include Icosavax, a firm specializing in vaccine development, including COVID-19 vaccines; as well as Tune Therapeutics; and GentiBio.